PATIENTS AND METHODS

Sedation
Seventy-six outpatients undergoing diagnostic, open, rigid bronchoscopy were admitted to the study. The patients were randomly allocated to three groups, which were similar as regards age, weight and height (table I). Any patient who had received a psychotropic drug or any other drug known to interact with benzodiazepines, or who could not perform the recovery tests before the drugs were administered, was excluded. The plan of investigation was approved by our institutional ethics committees, and informed consent was obtained from each patient. Topical anaesthesia of the respiratory tract was produced by the administration of lignocaine using an ultrasonic nebulizer (Korttila, Tarkkanen and Tarkkanen, 1981) . Fifteen millilitre of 4% lignocaine solution was introduced to the nebulizer chamber, and was atomized by oxygen for inhalation. Nebulization was continuous for 15 min during inspiration and expiration. The inhalation anaesthesia was supplemented using three 10-mg aliquots of 10% lignocaine solution, two sprayed into each vallecula and one on the epiglottis. Atropine 0.01 mg kg" 1 was injected i.v. and, 5 min later, the sedative was administered: diazepam 0.2 mg kg" 1 was injected to a cubital vein at a rate of 10 mg min" 1 , or midazolam 0.05 or 0.1 mg kg" 1 was given at the rate of 5 mg min" 1 . The patient, the bronchoscopist and the investigator were all unaware of the identity of the drug being administered.
Clinical observations, assessment of amnesia and subjective assessments Systolic and diastolic arterial pressures were measured by auscultation, and the heart rate was counted at the wrist before, during and after the procedure (Korttila et al., 1978a) .
Amnesia was assessed 2 h after injection of the sedative, when each patient was asked if he or she recalled insertion and removal of the bronchoscope. To evaluate the duration of the amnesic effect, we made additional use of two of the tests of clinical recovery: the patients were asked, 1 h and 2 h after injection of the sedative, if they could remember that their ability to stand steadily had been tested at 30 min, and their ability to walk along a straight line at 60 min, respectively.
The bronchoscopist rated both the adequacy of anaesthesia and patient co-operation (ease of bronchoscopy) using visual analogue scales from poor to good. The patient rated the acceptability of the procedure in the same manner.
Evaluation of recovery
The clinical recovery of the patient was determined using Romberg's test and by the patient's ability to walk along a straight line (Korttila, 1976) . Assessments were made when the patient arrived in the operating theatre and 30, 60 and 120 min after the injection of the sedative.
Visualization test (James, 1969) . The subject was required to trace each of 10 intermingled lines from their origins on the left side of a page to their termination on the right, without the aid of a finger. The score was the number of correct tracings per 3-min period.
Aiming test (James, 1969) . A piece of paper (20 cm X 30 cm) with 15 rows of 20 open circles (diameter 2 mm) was used. The subject had to place a dot inside each of as many circles as possible in 6 min. The dots were not to touch the edges of the circles. The score was based on the number of correct responses.
Perceptual speed test (Gelfman et al., 1979) . Using a set of numbers, the patient's task was to mark all the digits in a row which were identical with the one circled at the beginning of the row. The number of correct responses during a 2-min period was scored.
The three psychomotor paper-and-pencil tests were carried out before and 2 h after injection of the sedative.
Questionnaire
Each patient received a sealed envelope containing a questionnaire concerning the bronchoscopy and the patient's opinion of its acceptability (Korttila et al., 1978a) . The questionnaire was completed the day after the procedure.
Data analysis
Statistical analysis of the data was carried out using the non-parametric Chi-squared test and Student's t test for independent means between the groups and for dependent means within the groups.
RESULTS
The principal differences recorded between diazepam and midazolam were that midazolam 0.1 mg kg" 1 induced slightly more prolonged Cardiovascular effects and the performance of bronchoscopy After each sedative regimen, both systolic and diastolic arterial pressures remained almost unaltered during bronchoscopy. They were slightly lower (always by less than 16 mm Hg systolic and 7 mm Hg diastolic) thereafter. Heart rates increased by an average of 10 beat min" 1 after each of the sedatives.
The mean times (±SD) for performance of bronchoscopy varied according to the sedative used: diazepam 0.2 mg kg" 1 , 8.3 ± 5.1 min; midazolam 0.05 mg kg" 1 , 7.3 ± 4.0 min; midazolam 0.1 mg kg" 1 , 9.3 ± 6.4 min.
Subjective assessments
The efficacy of local anaesthesia, patient cooperation and acceptability of the procedure to patients were similar in each experimental group (table II) .
Amnesia to insertion and removal of the bronchoscope was significantly more common after diazepam 0.2 mg kg" 1 (P < 0.05) and midazolam 0.1 mg kg" 1 {P < 0.01) than after midazolam 0.05 mg kg" 1 ( 
Recovery
The patient's ability to stand steadily and walk along a straight line became normal significantly {P < 0.05 to P < 0.01) more slowly in those who received midazolam 0.1 mg kg" 1 than in patients who received midazolam 0.05 mg kg" 1 or diazepam (table IV) . Thirty minutes after the injection, 56%, , respectively, were unable to stand steadily. At 60 min, the corresponding figures for patients unable to walk along a straight line were 22%, 20% and 58%. All patients who had received diazepam were able to walk along a straight line 2 h after the injection, but 17% of patients receiving midazolam 0.1 mg kg" 1 were unable to do so (table IV) .
With the visualization, aiming and perceptual speed tests, there were no differences between patients of different sedative treatment groups (table  V) . Two hours after sedation, the patient's psychomotor performance in each test was similar to that measured before sedation.
Questionnaire
The acceptability of both sedation and the procedure were confirmed in each group (table VI) . No retrograde amnesia was associated with diazepam or midazolam administration. On the day after diazepam 0.2 mg kg" 1 and midazolam 0.1 mg kg" 1 , only 22% and 8% of patients, respectively, remembered bronchoscopy having been performed. After midazolam 0.05 mg kg" 1 , the figure was 52%. We wanted to assess midazolam as an i.v. sedative because findings during gastroscopy (Al-Khudhairi, Whitwam and McCloy, 1982; Brophy et al., 1982; Berggren et al., 1983; Bardhan et al., 1982) had indi-cated that midazolam might be preferable to diazepam for inducing mild sedation during short procedures.
The practice of early discharge of patients from hospital after outpatient procedures highlights the need to test for recovery after sedation. Both Romberg's test and the test of capacity to walk along a straight line are easy to perform, and are indices of the co-ordination skills which are affected to the greatest degree, and for the longest time, after sedation with benzodiazepines (Korttila and Linnoila, 1975, 1976; Korttila et al., 1978a) . These tests obviously do not indicate "street-fitness" or full psychomotor recovery, but can help clinicians to reach a decision regarding the discharge of patients after sedation or anaesthesia (Korttila, 1981) .
Visualization and aiming tests have been shown to be sensitive measures of mental function after cyclopropane anaesthesia (James, 1969) and flunitrazepam sedation (Korttila et al., 1978b) . Scores in the perceptual speed test have been shown to be impaired after sedation with diazepam and i.v. anaesthetics (Gelfman et al., 1979; Korttila et al., 1981) . We used these tests to study differences between recovery in various treatment groups, but found that, after midazolam, walking along a straight line was a more sensitive index of recovery than were these psychomotor tests.
Amnesia is less frequent to tactile stimuli than to events or visual stimuli following the administration of diazepam (Korttila, 1980a) . Bronchoscopy is a frightening and powerful tactile stimulus, and is easy to remember, which may explain why we did not find the greater degree of amnesia following midazolam, compared with diazepam, observed by other investigators (Whitwam, Al-Khudhairi and McCloy, 1983; Dixon et al., 1984) .
Our aim was to study doses of diazepam and midazolam which were similar in respect of amnesic action, and to compare side effects and recovery after such doses. Since the amnesia to bronchoscopy with diazepam 0.2 mg kg" 1 proved similar in this study to that with midazolam 0.1 mg kg" 1 , we considered comparison of rates of recovery after the two benzodiazepines at these doses to be justified.
Midazolam disappears from the blood much faster than diazepam. Its half-life (mean ±SD) during the elimination phase has been reported to be 2.4 ± 0.8 h (Allonen, Ziegler and Klotz, 1981 ) and 1.77 ± 0.83 h (Smith, Eadie and O' RourceBrophy, 1981) . That for diazepam is considerably longer (20-60 h) (Korttila, 1980b) . However, recent clinical studies, and our results, suggest that the rapid disappearance of midazolam from the blood is not associated with rapid recovery. Dixon and others (1984) Kawar and colleagues (1982) , using a pegboard test, found a similar recovery time in patients receiving midazolam 0.1 mg kg" 1 or diazepam 0.2 mg kg" 1 i.v.as a sedative in dentistry.
Our finding that the ability of patients to stand steadily and walk along a straight line reverted to normal more slowly after midazolam 0.1 mg kg" 1 than after diazepam 0.2 mg kg" 1 , reflects the failure of Kawar and colleagues (1982) , Whitwam, AlKhudhairi and McCloy (1983) , and Dixon and colleagues (1984) to demonstrate rapid recovery after midazolam, and suggests that testing the ability to walk along a straight line is a sensitive test for measuring the residual effects of midazolam. One explanation for the clinical finding that recovery from midazolam is not as fast as its pharmacokinetics would suggest, is that one metabolite of midazolam, a-hydroxy midazolam, has pharmacological activity. Crevoisier and others (1983) reported that a-hydroxymidazolam contributes to the central nervous system effects of midazolam, especially after oral administration.
Our conclusion is that, if doses of midazolam or diazepam, comparable in potency, are given during bronchoscopy, recovery of psychomotor function is not more rapid after sedation with midazolam than after sedation with diazepam.
